3Indexed trials
drug · Product Intelligence
Methylphenidate Hydrochloride
Pipeline Intelligence
Methylphenidate Hydrochloride: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 8 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
8FDA-linked events
Development evidence
NCT00249353McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · adhdPHASE3
NCT02247986National Institute of Mental Health (NIMH) · adhdPHASE1, PHASE2
NCT04152629Purdue Pharma, Canada · adhdPHASE4
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2020-10-28
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2019-05-23
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2018-11-30
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2017-05-11
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2016-10-21
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2016-02-29
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2015-11-13
FDA_APPROVALMETHYLPHENIDATE HYDROCHLORIDE · 2014-03-12
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.